Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory K Behbehani

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Cell Reports|July 30, 2023
Genetically modified IL2 bone-marrow-derived myeloid cells reprogram the glioma immunosuppressive tumor microenvironmentAlessandro Canella, Matthew Nazzaro, Sakthi Rajendran, et al.
Plos One|July 3, 2015
Reversibility of Defective Hematopoiesis Caused by Telomere Shortening in Telomerase Knockout MiceAparna Raval, Gregory K Behbehani, Le Xuan Truong Nguyen, et al.
Clinical Lung Cancer|November 25, 2020
Deep and Durable Response to Nivolumab and Temozolomide in Small-Cell Lung Cancer Associated With an Early Decrease in Myeloid-Derived Suppressor CellsDwight H Owen, Brooke Benner, Carly Pilcher, et al.
Nature Protocols|January 23, 2015
Palladium-based mass tag cell barcoding with a doublet-filtering scheme and single-cell deconvolution algorithmEli R Zunder, Rachel Finck, Gregory K Behbehani, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
<i>circPCMTD1</i> : A protein-coding circular RNA that regulates DNA damage response in <i>BCR/ABL</i> -positive leukemiasDimitrios Papaioannou, Amog P Urs, Rémi Buisson, et al.
Molecular Therapy. Oncology|June 27, 2024
Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 <i>in vitro</i> and <i>in vivo</i> in NB xenograftsYaya Chu, Gaurav Nayyar, Meijuan Tian, et al.
Nature Metabolism|June 15, 2021
Pre-operative exercise therapy triggers anti-inflammatory trained immunity of Kupffer cells through metabolic reprogrammingHongji Zhang, Tianmeng Chen, Jinghua Ren, et al.
Cell Reports Methods|July 5, 2022
Optimization and validation of CAR transduction into human primary NK cells using CRISPR and AAVMeisam Naeimi Kararoudi, Shibi Likhite, Ezgi Elmas, et al.
Molecular Therapy. Oncology|February 9, 2026
Erratum: Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 <i>in vitro</i> and <i>in vivo</i> in NB xenograftsYaya Chu, Gaurav Nayyar, Meijuan Tian, et al.
Leukemia & Lymphoma|September 24, 2019
Selinexor in combination with decitabine in patients with acute myeloid leukemia: results from a phase 1 studyBhavana Bhatnagar, Qiuhong Zhao, Alice S Mims, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Cell Reports|July 30, 2023
Genetically modified IL2 bone-marrow-derived myeloid cells reprogram the glioma immunosuppressive tumor microenvironmentAlessandro Canella, Matthew Nazzaro, Sakthi Rajendran, et al.
Plos One|July 3, 2015
Reversibility of Defective Hematopoiesis Caused by Telomere Shortening in Telomerase Knockout MiceAparna Raval, Gregory K Behbehani, Le Xuan Truong Nguyen, et al.
Clinical Lung Cancer|November 25, 2020
Deep and Durable Response to Nivolumab and Temozolomide in Small-Cell Lung Cancer Associated With an Early Decrease in Myeloid-Derived Suppressor CellsDwight H Owen, Brooke Benner, Carly Pilcher, et al.
Nature Protocols|January 23, 2015
Palladium-based mass tag cell barcoding with a doublet-filtering scheme and single-cell deconvolution algorithmEli R Zunder, Rachel Finck, Gregory K Behbehani, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2024
<i>circPCMTD1</i> : A protein-coding circular RNA that regulates DNA damage response in <i>BCR/ABL</i> -positive leukemiasDimitrios Papaioannou, Amog P Urs, Rémi Buisson, et al.
Molecular Therapy. Oncology|June 27, 2024
Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 <i>in vitro</i> and <i>in vivo</i> in NB xenograftsYaya Chu, Gaurav Nayyar, Meijuan Tian, et al.
Nature Metabolism|June 15, 2021
Pre-operative exercise therapy triggers anti-inflammatory trained immunity of Kupffer cells through metabolic reprogrammingHongji Zhang, Tianmeng Chen, Jinghua Ren, et al.
Cell Reports Methods|July 5, 2022
Optimization and validation of CAR transduction into human primary NK cells using CRISPR and AAVMeisam Naeimi Kararoudi, Shibi Likhite, Ezgi Elmas, et al.
Molecular Therapy. Oncology|February 9, 2026
Erratum: Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 <i>in vitro</i> and <i>in vivo</i> in NB xenograftsYaya Chu, Gaurav Nayyar, Meijuan Tian, et al.
Leukemia & Lymphoma|September 24, 2019
Selinexor in combination with decitabine in patients with acute myeloid leukemia: results from a phase 1 studyBhavana Bhatnagar, Qiuhong Zhao, Alice S Mims, et al.
Pageof 5